The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer

Recent studies have demonstrated the prognostic value of the C-reactive protein/albumin (CRP/Alb) ratio in cancer. However, the role of the CRP/Alb ratio in advanced pancreatic cancer (PC) has not been examined. A retrospective study of 233 patients with advanced PC was conducted. We investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Mengwan, Guo, Jing, Guo, Lihong, Zuo, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080377/
https://www.ncbi.nlm.nih.gov/pubmed/27344157
http://dx.doi.org/10.1007/s13277-016-5122-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080377/
https://www.ncbi.nlm.nih.gov/pubmed/27344157
http://dx.doi.org/10.1007/s13277-016-5122-y

Ejemplares similares